Nektar Therapeutics v. Quadrant Drug Delivery Ltd.
310 F. App'x 383
Opinion
ON MOTION
ORDER
Nektar Therapeutics moves to voluntarily dismiss its appeal.
Upon consideration thereof,
IT IS ORDERED THAT:
(1) Nektar Therapeutics’s motion is granted. The appeal is dismissed.
(2) Each side shall bear its own costs.
(3) All pending motions are moot.
Free access — add to your briefcase to read the full text and ask questions with AI
Nektar Therapeutics v. Quadrant Drug Delivery Ltd., 310 F. App'x 383 (Fed. Cir. 2008).
310 F. App'x 383 (Nektar Therapeutics v. Quadrant Drug Delivery Ltd.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.